PROCESS FOR PRODUCING FLUOROALLYLAMINE MONOAMINEOXIDASE INHIBITORS

摘要

Novel nonaromatic fluoroallylamines are potent MAO inhibitors and at low dose selectively inhibit MAO-B. They are useful in the treatment of depression and coadministered with L-dopa, in the treatment of Parkinsonism.